{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:16:07Z","timestamp":1784682967502,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23gm0010008h0003"],"award-info":[{"award-number":["23gm0010008h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJPF2022"],"award-info":[{"award-number":["JPMJPF2022"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMXP1323015483"],"award-info":[{"award-number":["JPMXP1323015483"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["2024-kokusai 1"],"award-info":[{"award-number":["2024-kokusai 1"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127451","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:12:52Z","timestamp":1751458372000},"page":"127451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["mRNA vaccination mitigates pathological retinochoroidal neovascularization in animal models"],"prefix":"10.1016","volume":"61","author":[{"given":"Yasuo","family":"Yanagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Bui Thao","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127451_bb0005","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127451_bb0010","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/s41433-022-02153-9","article-title":"15 years of anti-VEGF treatment for nAMD: success or failure or something in between?","volume":"36","author":"Chakravarthy","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.vaccine.2025.127451_bb0015","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1167\/iovs.07-0523","article-title":"Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model","volume":"49","author":"Takahashi","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2025.127451_bb0020","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1167\/iovs.07-0425","article-title":"Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2","volume":"48","author":"Mochimaru","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2025.127451_bb0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.127451_bb0030","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2025.127451_bb0035","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127451_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214320120","article-title":"Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment","volume":"120","author":"Tockary","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2025.127451_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/infdis\/jiad593","article-title":"Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than the gB\/MF59 vaccine","volume":"230","author":"Hu","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127451_bb0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127451_bb0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41433-021-01807-4","article-title":"LRG1 as a novel therapeutic target in eye disease","volume":"36","author":"De Rossi","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.vaccine.2025.127451_bb0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling","volume":"499","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127451_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-022-00790-6","article-title":"LRG1: an emerging player in disease pathogenesis","volume":"29","author":"Camilli","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2025.127451_bb0070","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/s41467-023-38244-8","article-title":"Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures","volume":"14","author":"Inagaki","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127451_bb0075","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ymthe.2024.03.022","article-title":"Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity","volume":"32","author":"Abbasi","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.127451_bb0080","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.3390\/ijms22168879","article-title":"LRG1 expression is elevated in the eyes of patients with Neovascular age-related macular degeneration","volume":"22","author":"Mundo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2025.127451_bb0085","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2025.127451_bb0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.bbrc.2009.03.104","article-title":"Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response","volume":"382","author":"Shirai","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2025.127451_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127451_bb0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","article-title":"Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study","volume":"371","author":"Tissot","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127451_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060493","article-title":"Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice","volume":"8","author":"Nakagami","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127451_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41541-022-00544-3","article-title":"Immunogenicity of MultiTEP platform technology-based tau vaccine in non-human primates","volume":"7","author":"Hovakimyan","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127451_bb0115","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of a\u03b2 immunization (AN1792) in patients with AD in AN interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2025.127451_bb0120","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1200\/JCO.23.02376","article-title":"Phase I\/II study of a vascular endothelial growth factor receptor vaccine in patients with NF2-related Schwannomatosis","volume":"42","author":"Tamura","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:21:51Z","timestamp":1778534511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"alternative-id":["S0264410X25007480"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127451","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA vaccination mitigates pathological retinochoroidal neovascularization in animal models","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127451"}}